Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase I...
Leadership
David G. Elsley MBA
President, CEO & Director
Bernard Lim B.Sc.
Chief Operating Officer
Andrew Warwick Hamer M.D.
Chief Medical Officer and Head of Research & Development
